See more : Hong Leong Bank Berhad (5819.KL) Income Statement Analysis – Financial Results
Complete financial analysis of General Biologicals Corporation (4117.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of General Biologicals Corporation, a leading company in the None industry within the None sector.
You may be interested
- Nueva Expresión Textil, S.A. (NXT.MC) Income Statement Analysis – Financial Results
- The Karnataka Bank Limited (KTKBANK.NS) Income Statement Analysis – Financial Results
- Tradestar Resources Corporation (TSRR) Income Statement Analysis – Financial Results
- Chelyabinsk Forge-and-Press Plant, Public Joint Stock Company (CHKZ.ME) Income Statement Analysis – Financial Results
- M.T.I Wireless Edge Ltd. (MWE.L) Income Statement Analysis – Financial Results
General Biologicals Corporation (4117.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 264.83M | 370.46M | 551.66M | 475.87M | 239.65M |
| Cost of Revenue | 202.12M | 198.61M | 269.72M | 224.81M | 112.81M |
| Gross Profit | 62.71M | 171.85M | 281.94M | 251.06M | 126.84M |
| Gross Profit Ratio | 23.68% | 46.39% | 51.11% | 52.76% | 52.93% |
| Research & Development | 33.11M | 35.85M | 34.25M | 41.13M | 35.81M |
| General & Administrative | 97.17M | 85.17M | 84.41M | 82.78M | 64.66M |
| Selling & Marketing | 106.24M | 95.41M | 135.24M | 64.06M | 64.20M |
| SG&A | 203.41M | 180.58M | 219.64M | 146.84M | 125.57M |
| Other Expenses | -3.88M | 11.87M | 5.49M | 11.10M | 0.00 |
| Operating Expenses | 232.64M | 216.43M | 253.89M | 187.98M | 161.46M |
| Cost & Expenses | 434.76M | 415.04M | 523.61M | 412.79M | 274.27M |
| Interest Income | 2.66M | 1.08M | 490.00K | 181.00K | 254.00K |
| Interest Expense | 11.98M | 16.86M | 11.00M | 3.32M | 4.68M |
| Depreciation & Amortization | 36.68M | 35.92M | 35.73M | 30.91M | 19.46M |
| EBITDA | -139.06M | 7.99M | 69.60M | 102.23M | -15.08M |
| EBITDA Ratio | -52.51% | 0.79% | 12.62% | 21.48% | -6.29% |
| Operating Income | -169.94M | -32.98M | 33.87M | 71.32M | -34.54M |
| Operating Income Ratio | -64.17% | -8.90% | 6.14% | 14.99% | -14.41% |
| Total Other Income/Expenses | -17.78M | -13.15M | 4.74M | -14.79M | -4.51M |
| Income Before Tax | -187.72M | -46.13M | 38.61M | 48.29M | -39.05M |
| Income Before Tax Ratio | -70.88% | -12.45% | 7.00% | 10.15% | -16.29% |
| Income Tax Expense | 12.13M | 7.69M | -5.48M | -13.80M | 0.00 |
| Net Income | -198.83M | -53.19M | 44.14M | 62.15M | -39.05M |
| Net Income Ratio | -75.08% | -14.36% | 8.00% | 13.06% | -16.29% |
| EPS | -3.32 | -0.89 | 0.74 | 1.18 | -0.99 |
| EPS Diluted | -3.32 | -0.89 | 0.74 | 1.18 | -0.99 |
| Weighted Avg Shares Out | 59.83M | 59.83M | 59.83M | 52.75M | 39.48M |
| Weighted Avg Shares Out (Dil) | 59.83M | 59.83M | 59.91M | 52.81M | 39.48M |
No news found for: 4117.TWO
Source: https://incomestatements.info
Category: Stock Reports